1. Burdakov D, Liss B, Ashcroft FM. Orexin excites GABAergic neuron of the arcuate nucleus by activating the sodium-calcium exchanger. J Neurosci. 2003. 25:4951–4957.
2. Chen W, Matuda K, Nishimura N, Yokogoshi H. The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet. Life Sci. 2004. 27(74):1889–1898.
Article
3. Elisaf M, Karabina SA, Bairaktari E, Goudevenos JA, Siamopoulos KC, Tselepis AD. Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia. Platelets. 1999. 10:124–131.
Article
4. Folch J, Lees M, Sloane stanley GH. A simple method for the isolation and rification of total lipids from animal tissues. J Biol chem. 1957. 226:497–509.
Article
5. Friedrich B, Matskevich I, Lang F. Cell volume regulatory mechanisms. Contrib Nephrol. 2006. 152:1–8.
Article
6. Hakam AC, Hussain T. Angiotensin type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zuker rats. Hypertension. 2006. 47:1117–1124.
Article
7. Hall JA, Kirk J, Potts JR, Rae C, Kirk K. Anion channel blockers inhibit swelling-activated anion, cation and nonelectrolyte transport in HeLa cells. Am J Physiol. 1996. 271:C579–C588.
Article
8. Handa RK, Stranhoy JW. Platelet activating factor (PAF) and solute transport process in the kidney. Am J Physiol Renal Physiol. 2003. 284:274–281.
9. Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992. 72:101–163.
Article
10. Igisu H, Izumi K, Goto I, Kina K. Effects of taurine on the ATPase activity in the human erythrocyte membrane. Pharmacology. 1976. 14:362–366.
Article
11. Kang JS, Cregor MD, Smith JB. Effect of calcium on blood pressure, platelet aggregation and erythrocyte sodium transport in Dahl salt-sensitive rats. J Hypertens. 1990. 8:245–250.
12. Kontro P, Oja SS. Taurine and GABA release from mouse cerebral cotex slice: effects of structural analogues and drugs. Neurochem Res. 1987. 12:475–482.
Article
13. Kurup RK, Kurup PA. Hypothalamic digoxin, hemispheric chemical dominance, and Alzheimer's disease. Int J Neurosci. 2003. 113:361–381.
Article
14. Lijnen P, Petrov V. Cholesterol modulation of transmembrane cation transport systems in human erythrocytes. Biochem Mol Med. 1995. 56:52–62.
Article
15. Liu CH, Huang MT, Huang PC. Source of triglyceride accumulation in liver of rats fed a cholesterol supplemented diet. Lipids. 1995. 30:527–531.
Article
16. Mayol V, Duran MJ, Gerbi A, Levy S, Sampol J, Maixent JM. Cholesterol and omega 3 fatty acids inhibit Na-K ATPase activity in human endothelial cells. Atherosclerosis. 1999. 142:327–333.
Article
17. McCarty MF. Sub-optimal taurine status may promote platelet hyperaggregability in vegetarians. Med Hypotheses. 2004. 63:426–433.
Article
18. Mochizuki H, Takido J, Oda H, Yokogoshi H. Improving effect of dietary taurine on marked hypercholesterolemia induced by a high cholesterol diet in streptozotocin induced diabetic rats. Biosci Biotechnol Biochem. 1999. 63:1984–1987.
Article
19. Mrsny RJ, Meizel S. Inhibition of hamster sperm Na+, K+-ATPase activity by taurine and hypotaurine. Life Sci. 1985. 36:271–275.
Article
20. Murakami S, Kondo Y, Toda Y, Kitajima H, Kameo K, Sakono M, Fukuda N. Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci. 2002. 70:2355–2366.
Article
21. Oh IS, Kang JA, Kang JS. Gender difference in the effects of gonadectomy and hypercholesterol diet on plasma and liver cholesterol and TG levels, platelet aggregation and liver tissue in Sprague Dawley rats. Nutritional Sciences. 2002. 35:15–23.
22. Qi B, Yamagami T, Naruse Y, Sokejima S, Kagamimori S. Effect of taurine on depletion of erythrocyte membrane Na-K ATPase activity due to ozone exposure or cholesterol enrichment. J Nutr Sci Vitaminol. 1995. 41:627–634.
Article
23. Rabini RA, Staffolani R, Martarelli D, Fumelli P, Ravaglia F, Dousset N, Curatola G, Mazzanti L. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions. J Clin Endocrinol Metab. 1999. 84:3770–3774.
Article
24. Shefer S, Nguyen LB, Salen G, Ness GC, Chowdhary IR, Lerner S, Batta AK, Tint GS. Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat. J Lipid Res. 1992. 33:1193–2000.
Article
25. Smith JB, Ash KO, Sprowell WL, Hentchel WM, Williams RR. An improved non-radioisotopic method for increasing ouabain sensitive Na efflux from erythrocytes. Clin Chim Acta. 1984. 143:295–299.
Article
26. Sobolová L, Skottová N, Vecera R, Urbánek K. Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats. Pharmacol Res. 2006. 53:104–112.
Article
27. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, Williams DL. Differential effects of dietary fat on the tissue specific expression of apo A-1 gene; relationship to plasma concentration of high density lipoproteins. J Lipid Res. 1989. 30:1397–1403.
Article
28. Thut PD, Hruska RE, Huxtable RJ, Bressler R. Huxtable RJ, Barbeau A, editors. Effect of taurine on eating and drinking behavior. Taurine. 1976. USA: New York Raven;357–364.
29. Tranquilli AL, Cester N, Nanetti L, Mazzanti L. Plasma lipids and physicochemical properties of the erythrocyte plasma membrane throughout pregnancy. Acta Obstet Gynecol Scand. 2004. 83:443–448.
Article
30. Tufft LS, Jensen LS. Influence of dietary taurine on performance and fat retention in broilers and turkey poults fed varying levels of fat. Poult Sci. 1992. 71:880–885.
Article
31. Winocour PD, Vickers JD, Kinlough-Rathbone RL, Packham MA, Mustard JF. Thrombin-induced inositol phosphate production by platelets from rats with diet induced or genetically determined hypercholesterolemia. J Lab Clin Med. 1990. 115:241–248.
32. Yamamoto K, Yoshitama A, Sakono M, Nasu T, Murakami S, Fukuda N. Dietary taurine decreases hepatic secretion of cholesterol ester in rats fed a high-cholesterol diet. Pharmacology. 2000. 60:27–33.
Article
33. Yoshimura H, Nariai Y, Terashima M, Mitani T, Tanigawq Y. Taurine suppresses platelet derived growth factor (PDGF) BB-induced PDGF-beta receptor phosphorylation by protein tyrosine phosphatase-mediated dephosphorylation in vascular smooth muscle cells. Biochim Biophys Acta. 2005. 1745:350–360.
Article
34. Zicha J, Negrin CD, Dobesová Z, Kunes J, Dominiczak AF. Altered Na+-K+ pump activity and plasma lipids in salt-hypertensive Dahl rats: relationship to Atp1a1 gene. Physiol Genomics. 2001. 6:99–104.
Article